About ParaGen Technologies
ParaGen Technologies is a company based in Columbus (United States) founded in 2016 by Flavio Lobato. ParaGen Technologies has raised $11.64 million across 4 funding rounds from investors including Ikove Capital Partners. The company has 1 employees as of July 01, 2024. ParaGen Technologies offers products and services including Nanofiber Scaffolds, RenovoDerm, Atreon Orthopedics, Vascular Genesis, and Tarian Medical. ParaGen Technologies operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and SINTX, among others.
- Headquarter Columbus, United States
- Employees 1 as on 01 Jul, 2024
- Founders Flavio Lobato
-
Sectors
HealthcareChemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Paragen Technologies
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.64 M (USD)
in 4 rounds
-
Latest Funding Round
$4.45 M (USD), Series A
Nov 16, 2021
- Investors
-
Employee Count
1
as on Jul 01, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ParaGen Technologies
ParaGen Technologies offers a comprehensive portfolio of products and services, including Nanofiber Scaffolds, RenovoDerm, Atreon Orthopedics, Vascular Genesis, and Tarian Medical.
Scaffolds that mimic body structures to promote tissue healing and regeneration
Product for wound healing using nanofiber technology
Device for orthopedic repair with nanofiber scaffolds
Product for vascular regeneration via nanofiber technology
Device for hernia repair using synthetic scaffolds
People of ParaGen Technologies
Unlock access to complete
Unlock access to complete
Leadership Team
5 people
Board Team
4 people
CTO Team
1 people
COO Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of ParaGen Technologies
ParaGen Technologies has successfully raised a total of $11.64M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $4.45 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ParaGen Technologies
ParaGen Technologies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ikove Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for ParaGen Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ParaGen Technologies
Investment portfolio details for ParaGen Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ParaGen Technologies
Detailed financials for ParaGen Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Paragen Technologies Comparisons
Peer comparison for ParaGen Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ParaGen Technologies
ParaGen Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and SINTX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Silicon nitride medical devices are manufactured for interbody fusion.
|
|
| Locked | Locked | Locked |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
Detailed competitors of ParaGen Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Paragen Technologies
Complete news archive for ParaGen Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ParaGen Technologies
ParaGen Technologies was founded in 2016 and raised its 1st funding round 1 year after it was founded.
ParaGen Technologies is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Ross Kayuha is the current CEO of ParaGen Technologies.
ParaGen Technologies is a funded company, having raised a total of $11.64M across 4 funding rounds to date.
As of Jul 01, 2024, the latest employee count at ParaGen Technologies is 1.
ParaGen Technologies was founded in 2016 in Columbus, United States, focusing on the tissue engineering sector. Synthetic nanofiber scaffolds are created by the company to replicate the extracellular matrix, supporting healing processes. Applications include wound care, orthopedics, vascular treatments, and hernia repair, with operations centered on advancing medical biomaterials for regenerative purposes.
ParaGen Technologies offers Nanofiber Scaffolds, RenovoDerm, Atreon Orthopedics, Vascular Genesis, and Tarian Medical.
ParaGen Technologies has 1 investor. Key investors include Ikove Capital Partners.